Solitary pulmonary cholesteroloma, multiple xanthelasmas and lipemia retinalis complicating hypercholesterolemia after bone marrow transplantation

Bone Marrow Transplantation

Volumn 18, Issue 2, 1996, Pages 457-459

  Toren, A ^a,b   Nagler, A ^c,d  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Cytomegalovirus infection; Graft versus host disease; Hypercholesterolemia; Hyperlipidemia; Lipemia retinalis; Xanthelasma

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; MEVINOLIN;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INTRAHEPATIC CHOLESTASIS; LIPOPROTEIN BLOOD LEVEL; LUNG DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL; RETINA DISEASE; SKIN DISEASE; T CELL LYMPHOMA;

ADULT; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS INFECTIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; HYPERCHOLESTEROLEMIA; LUNG DISEASES; RETINAL DISEASES; XANTHOMATOSIS;

EID: 0029830691     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Phair PG, Powell HR, McCredie DA. Lipid abnormalities in red blood cells and plasma phospholipids in cyclosporine-treated heart transplant recipients. Transplant Proc 1994; 26: 3722-3726.
2. Azrolan N, Brown CD, Thomas L et al. Cyclosporine A has divergent effects on plasma LDL cholesterol and lipoprotein (a) levels in renal transplant recipients. Evidence for renal involvement in the maintenance of LDL cholesterol and elevation of lipoprotein (a) concentration in hemodialysis patients. Arterioscler Thromb 1994; 14: 1393-1398.
3. Waldmann H, Polliack A, Hale G. Elimination of graft versus-host disease by in vitro depletion of alloreactive lymphocytes with a monoclonal anti-human lymphocyte antibody (Campath-1). Lancet 1984; ii: 483-485.
4. Shuhart MC, McDonald GB. Gastrointestinal and hepatic complications. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific: Boston, 1994, pp 454-481.
5. Arnon R, Raz I, Chajek-Shaul T et al. Amiodarone pulmonary toxicity presenting as a solitary lung mass. Chest 1988; 93: 425-427.
6. Heyl AG. Intra-ocular lipemia. Trans Am Ophthalmol Soc 1880; 3: 55-59.
7. Vinger PF, Sachs BA. The ocular manifestations of hyperlipoproteinemia. Am J Ophthalmol 1979; 70: 563-569.
8. Hidalgo L, Lopez-Miranda J, Espino A et al. Effect of lovastatin and bezafibrate on cyclosporine-induced hyperlipidemia. Transplant Proc 1995; 27: 1857-1861.
9. Nimer SD, Champlin RE, Golde DW. Serum cholesterol-lowering activity of granulocyte-macrophage colony-stimulating factor. J Am Med Assoc 1988; 260: 3297-3300.
10. Stoudemire J, Garnick MB. Effect of recombinant human macrophage colony stimulating factor on plasma cholesterol levels. Blood 1991; 77: 750-755.
11. Takahashi M, Nikkuni K, Moriyama Y, Shibata A. GM-CSF-mediated impairment of liver to synthesize albumin, cholinesterase, and cholesterol. Am J Hematol 1991; 36: 213-214.
12. Dann FJ, Friedlander Y, Leitersdorf E, Nagler A. The modulation of plasma lipids and lipoproteins during bone marrow transplantation is unrelated to exogenously administered recombinant human granulocyte-monocyte colony-stimulating factor (rHu GM-CSF). Leukemia Res (submitted).